DECISION OF THE EEA JOINT COMMITTEE No 201/2020

of 11 December 2020

amending Annex II (Technical regulations, standards, testing and certification) to the EEA Agreement [2023/2003]

THE EEA JOINT COMMITTEE,

Having regard to the Agreement on the European Economic Area (“the EEA Agreement”), and in particular Article 98 thereof,

Whereas:

(1) Commission Implementing Decision (EU) 2019/1244 of 1 July 2019 amending Decision 2002/364/EC as regards requirements for HIV and HCV antigen and antibody combined tests and as regards requirements for nucleic acid amplification techniques with respect to reference materials and qualitative HIV assays  ( 1 ) is to be incorporated into the EEA Agreement.

(2) Annex II to the EEA Agreement should therefore be amended accordingly,

HAS ADOPTED THIS DECISION:

Article 1

The following indent is added in point 3 (Commission Decision 2002/364/EC) of Chapter XXX of Annex II to the EEA Agreement:

‘—

32019 D 1244 : Commission Implementing Decision (EU) 2019/1244 of 1 July 2019 ( OJ L 193, 19.7.2019, p. 1 ).’

Article 2

The text of Implementing Decision (EU) 2019/1244 in the Icelandic and Norwegian languages, to be published in the EEA Supplement to the Official Journal of the European Union , shall be authentic.

Article 3

This Decision shall enter into force on 12 December 2020, provided that all the notifications under Article 103(1) of the EEA Agreement have been made  ( *1 ) .

Article 4

This Decision shall be published in the EEA Section of, and in the EEA Supplement to, the Official Journal of the European Union .

Done at Brussels, 11 December 2020.

For the EEA Joint Committee

The President

Sabine MONAUNI

( 1 )    OJ L 193, 19.7.2019, p. 1 .

( *1 )   No constitutional requirements indicated.